NCT06541847
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06541847
Title A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1 (INSPIRE-NF1)
Acronym INSPIRE-NF1
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Healx Limited
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.